Right ventricular dysfunction during chemotherapy in patients with breast cancer
Aim. To assess the right ventricle (RV) during chemotherapy (CT) in patients with breast cancer (BC).Material and methods. The study included 40 women aged 35-72 years with BC who underwent anthracycline chemotherapy. The main group (n=40) included women with BC, examined at the first contact, 37 of...
Saved in:
| Main Authors: | A. N. Sumin, Yu. S. Slepynina, А. V. Shcheglova, A. V. Ivanova, O. M. Polikutina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2022-06-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/3182 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High-sensitivity troponin I as a predictor of left ventricular dysfunction in the use of cardiotoxic anticancer agents for breast cancer in patients with predominantly low and moderate risk of cardiotoxicity
by: V. D. Levina, et al.
Published: (2022-12-01) -
The importance of the Autostrain RV technique in the treatment of right ventricular myocardial alterations in patients with breast cancer receiving chemotherapy
by: Yan Liang, et al.
Published: (2025-01-01) -
Prognostic value of humoral markers in patients with anthracycline-related cardiac dysfunction
by: E. V. Grakova, et al.
Published: (2023-10-01) -
Incidence of Right Ventricular Dysfunction in an Echocardiographic Referral Cohort
by: Jonah D. Garry, et al.
Published: (2025-07-01) -
Cardioprotective effect of crocin in patients with breast cancer receiving anthracycline-based chemotherapy: A randomized, double-blind, placebo-controlled study
by: Xinye Li, et al.
Published: (2025-03-01)